EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 54 filers reported holding EDGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $150,000 | -22.3% | 471,620 | +100.0% | 0.00% | – |
| Q3 2018 | $193,000 | -21.9% | 235,810 | -1.8% | 0.00% | – |
| Q2 2018 | $247,000 | +3.8% | 240,153 | +18.8% | 0.00% | – |
| Q1 2018 | $238,000 | -86.6% | 202,069 | +6.9% | 0.00% | -100.0% |
| Q4 2017 | $1,771,000 | -11.0% | 189,099 | +1.9% | 0.00% | 0.0% |
| Q3 2017 | $1,991,000 | +6.1% | 185,583 | +1.4% | 0.00% | 0.0% |
| Q2 2017 | $1,877,000 | +19.4% | 183,008 | +6.0% | 0.00% | 0.0% |
| Q1 2017 | $1,572,000 | -23.5% | 172,646 | +5.0% | 0.00% | 0.0% |
| Q4 2016 | $2,055,000 | +22.4% | 164,465 | +1.9% | 0.00% | 0.0% |
| Q3 2016 | $1,679,000 | +120.9% | 161,352 | +114.6% | 0.00% | – |
| Q2 2016 | $760,000 | +24.6% | 75,200 | +12.7% | 0.00% | – |
| Q1 2016 | $610,000 | -19.8% | 66,744 | +9.6% | 0.00% | – |
| Q4 2015 | $761,000 | – | 60,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |